RCM
CELUW icon

Radcliffe Capital Management’s Celularity Inc CELUW Stock Holding History

Radcliffe Capital Management’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,782
Closed -$130K – 901
2021
Q2 		$130K Hold
12,782
– – ﹤0.01% 907
2021
Q1 		$129K Buy
+12,782
New +$19.9K 0.01% 681

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $187M AUM 179.87% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Radcliffe Capital Management's CELUW Position: Q3 2021 in Review

Radcliffe Capital Management sold out of Celularity Inc (CELUW) in Q3 2021, closing a stake of 12,782 shares — an estimated $130K sold.

Radcliffe Capital Management first reported a position in CELUW in Q1 2021 and held it in 2 quarters. The position peaked at $130K in Q2 2021. 24 funds tracked by Wall St. Rank hold CELUW as of Q3 2021.

  • Radcliffe Capital Management reported no remaining Celularity Inc position as of Q3 2021 after selling out during the quarter.
  • Radcliffe Capital Management sold 12,782 Celularity Inc shares in Q3 2021, an estimated $130K.
  • Radcliffe Capital Management first reported a position in Celularity Inc in Q1 2021 and held it in 2 quarters.
  • Radcliffe Capital Management's Celularity Inc position peaked at $130K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Celularity Inc as of Q3 2021.

Based on Radcliffe Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.